Michael Benatar, MD
Enriched profileProfessor of Neurology and Public Health Sciences; Chief, Neuromuscular Division; Vice Chair for Clinical and Translational Research, Department of Neurology; Executive Director, The ALS Center; Walter Bradley Chair in ALS Research · University of Miami Miller School of Medicine
Michael Benatar is Professor of Neurology and Public Health Sciences; Chief, Neuromuscular Division; Vice Chair for Clinical and Translational Research, Department of Neurology; Executive Director, The ALS Center; Walter Bradley Chair in ALS Research at University of Miami Miller School of Medicine. ClinicalTrials.gov lists 12 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 2 Sept 2026
Michael Benatar, MD, is Professor of Neurology and Public Health Sciences at University of Miami Miller School of Medicine. The public record shows 41 publications with 1,968 citations (h-index 11), centered on ALS. It also documents an investigator role on 12 registered clinical trials, industry payments reported by 13 companies, 9 NIH-funded awards (2008–2026).
- Top research focus: ALS
- 12 registered trials on ClinicalTrials.gov
- Open Payments reporting from 13 companies
Generated from the cited public record · current as of 2 Sept 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 2 Sept 2026
Listed as an investigator on 12 registered studies on ClinicalTrials.gov. The most recent:
- Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
Sponsor: Vector Y Therapeutics
- Phenotype, Genotype and Biomarkers 2
Sponsor: University of Miami
- TRIAL READY (Clinical Trial Readiness)
Sponsor: University of Miami
Industry payments
Updated 2 Sept 2026
13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Biogen, Inc.Program year20256 payments
- Alexion Pharmaceuticals, Inc.Program year20251 payment
- Eli Lilly and CompanyProgram year20242 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
38.1%Purine Antimetabolite38.1%Azathioprine100%Part D≥17 patientsMetabolism & gastrointestinal
37.6%Corticosteroid37.6%Prednisone100%Part D≥17 patientsNervous system
24.3%Cholinesterase Inhibitor24.3%Pyridostigmine Bromide100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 2 Sept 2026
9 NIH research awards on record, funded 2008–2026 per NIH RePORTER. The latest:
- Clinical Centers for the NINDS NeuroNEXT(Network of Excellence in Neuroscience Clinical Trials) Consortium
University of Miami School of Medicine
FY2026$410,210U24NS107376 - Pre-Symptomatic Familial ALS (Pre-fALS) Study: From Prodrome and Biomarkers to ALS/FTD Prevention
University of Miami School of Medicine
FY2025$11,282,768RF1NS105479 - Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe)
University of Miami School of Medicine
FY2025$1,804,011U54NS092091
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Online presence
Updated 2 Sept 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Other
orcid.org/0000-0003-4241-5135
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗ - Doximity
doximity.com/pub/michael-benatar-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Michael-Benatar-39949355
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- X / Twitter
x.com/UMiamiNeuro/status/1743238846752407591
- X / Twitter
x.com/umiamimedicine/status/1451655161932308491
- YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 2 Sept 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
- Neurology Residency and Neurophysiology Fellowship
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →miami-als.org ↗ - Board Certified
American Board of Psychiatry and Neurology - Neurology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - Board Certified
American Board of Psychiatry and Neurology - Clinical Neurophysiology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →clinician.nejm.org ↗
- Trustee
The ALS Association Board of Trustees; Chair, Research Committee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theorg.com ↗ - Editorial board member
Cochrane Collaboration Neuromuscular Disease Group
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →clinician.nejm.org ↗
Awards & honors
honors on the public record- Sean M. Healey International Prize for Innovation in ALS
presented at the 34th International Symposium on ALS/MND
2024verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →miami-als.org ↗
Secondary affiliations
appointments beyond the home institution- Principal Investigator
Pre-Symptomatic Familial ALS (Pre-fALS) Study
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - Principal Investigator
CReATe Consortium (Clinical Research in ALS and Related Disorders for Therapeutic Development, rare disease clinical research network)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - Co-Chair
American Academy of Neurology Evidence-Based Medicine Working Group
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →clinician.nejm.org ↗
Media & interviews
press, podcasts and appearances- The Genetics Podcast
Episode 121: "Breakthroughs and insights in ALS research with Dr. Michael Benatar"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →miami-als.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →jnnpbmj.podbean.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Mario Sznol, MD
University of Miami Miller School of Medicine
Joshua Hare, MD
University of Miami Miller School of Medicine
Felipe Medeiros, MD
University of Miami Miller School of Medicine
Jeffrey Goldberger, MD
University of Miami Miller School of Medicine